Revenue Beat and Stable Year-over-Year
Q1 revenue of $16.9M exceeded the company's guidance range of $16.3M–$16.7M and was slightly higher than Q1 2025 ($16.8M), representing a ~+0.6% YoY increase. (Note: revenue was down QoQ from $19.4M, -12.9%.)
Gross Margin Outperformance
GAAP gross margin was 62.2%, above guidance (57%–59%) and up 1.7 percentage points vs. Q4 2025 (60.5%). Non-GAAP gross margin was 65.2%, up 1.3 percentage points from Q4 2025 (63.9%).
Product Adoption and Commercial Momentum in AV
Strong adoption of new chips: VS3000 (unique uncompressed HDMI 2.0 extension) and VS6320 (first dedicated USB 3.2 extension chip). Notable customer rollout: Extron’s DTP3 CrossPoint 42 series uses VS3000. Positive demonstrations and visibility at CES and ISE increased market interest in multi-camera extension, uncompressed 4K+USB3 single-box solutions and USB-C extension scenarios.
Automotive Traction and Industry Milestone (A-PHY)
Automotive revenue grew to $5.9M (35% of revenue), up ~+7.3% QoQ and +15.7% YoY. VA7000 chipset (MIPI A-PHY compliant) achieved a first-of-its-kind three-company interoperable demonstration at Auto China — a meaningful validation of the A-PHY ecosystem and a differentiator for OEMs concerned about vendor lock-in.
Segment Profitability and Mix Benefits
Cross-Industry Business (CIB) gross margin was 70.8% and Automotive margin was 46.2% in Q1. The sequential increase in CIB margin versus Q4 was attributed to product mix, supporting higher overall gross margin.
Operating Expense Discipline
Total operating expenses declined to $19.4M in Q1 from $20.9M in Q4 2025. R&D decreased to $10.3M (from $11.1M) and SG&A decreased to $9.4M (from $10.1M), showing cost control progress.
Improved Near-Term Adjusted EBITDA vs Guidance and Strong Balance Sheet
Adjusted EBITDA loss was $5.5M — a smaller loss than the guidance range ($7.9M–$7.5M). The company ended Q1 with $86.1M in cash, cash equivalents and short-term deposits and no debt, providing runway for product commercialization and investments.
Confident Outlook and Unchanged Full-Year Guide
Q2 revenue guidance of $17.2M–$17.6M (midpoint $17.4M) and unchanged full-year guidance of $75M–$77M reflect management confidence in product design-ins and expected second-half acceleration driven by customer product launches.